These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33273176)

  • 1. Neurotoxicity of Cancer Therapies.
    Dietrich J
    Continuum (Minneap Minn); 2020 Dec; 26(6):1646-1672. PubMed ID: 33273176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic Complications of Cancer Therapies.
    Lee EQ
    Curr Neurol Neurosci Rep; 2021 Nov; 21(12):66. PubMed ID: 34817688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Drugs and the Nervous System.
    Santomasso BD
    Continuum (Minneap Minn); 2020 Jun; 26(3):732-764. PubMed ID: 32487905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic complications of cancer drug therapies.
    Lee EQ; Arrillaga-Romany IC; Wen PY
    Continuum (Minneap Minn); 2012 Apr; 18(2):355-65. PubMed ID: 22810132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system injury from novel cancer immunotherapies.
    Winter SF; Vaios EJ; Dietrich J
    Curr Opin Neurol; 2020 Dec; 33(6):723-735. PubMed ID: 32941192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticancer Drugs and the Nervous System].
    Fukutake T
    Brain Nerve; 2021 Jan; 73(1):21-33. PubMed ID: 33361511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurologic Toxicities of Cancer Immunotherapies: a Review.
    Harrison RA; Tummala S; de Groot J
    Curr Neurol Neurosci Rep; 2020 Jun; 20(7):27. PubMed ID: 32514633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging findings in cancer therapy-associated neurotoxicity.
    Arrillaga-Romany IC; Dietrich J
    Semin Neurol; 2012 Sep; 32(4):476-86. PubMed ID: 23361490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological toxicities associated with immune-checkpoint inhibitors.
    Touat M; Talmasov D; Ricard D; Psimaras D
    Curr Opin Neurol; 2017 Dec; 30(6):659-668. PubMed ID: 28938341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of Neurologic Injury following Oncologic Therapy.
    Ouyang T; Kanekar S
    Radiol Clin North Am; 2021 May; 59(3):425-440. PubMed ID: 33926687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic Complications of Systemic Anticancer Therapy.
    Ly KI; Arrillaga-Romany IC
    Neurol Clin; 2018 Aug; 36(3):627-651. PubMed ID: 30072074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurologic complications of chemotherapy and radiation therapy.
    Nolan CP; DeAngelis LM
    Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):429-51. PubMed ID: 25837905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological sequelae of cancer immunotherapies and targeted therapies.
    Wick W; Hertenstein A; Platten M
    Lancet Oncol; 2016 Dec; 17(12):e529-e541. PubMed ID: 27924751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe neurologic complications of immune checkpoint inhibitors: a single-center review.
    Mancone S; Lycan T; Ahmed T; Topaloglu U; Dothard A; Petty WJ; Strowd RE
    J Neurol; 2018 Jul; 265(7):1636-1642. PubMed ID: 29761297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature.
    Reynolds KL; Guidon AC
    Oncologist; 2019 Apr; 24(4):435-443. PubMed ID: 30482825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central Nervous System Complications Among Oncology Patients.
    Winter SF; Jo J; Schiff D; Dietrich J
    Hematol Oncol Clin North Am; 2022 Feb; 36(1):217-236. PubMed ID: 34607715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition.
    Pan PC; Haggiagi A
    Curr Oncol Rep; 2019 Nov; 21(12):108. PubMed ID: 31776691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, Treatment, and Complications of Central Nervous System Metastases.
    Pruitt AA
    Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1580-1600. PubMed ID: 29200112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy.
    Perrinjaquet C; Desbaillets N; Hottinger AF
    Curr Opin Neurol; 2019 Jun; 32(3):500-510. PubMed ID: 30893101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologic adverse events of cancer immunotherapy.
    Brito MH
    Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):270-280. PubMed ID: 35976306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.